Search
for
Sort by
Research 211–240 of 1000+
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Under Development JAK Inhibitors for Dermatologic Diseases
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Alopecia areata
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Deuruxolitinib for Alopecia Areata.
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Baricitinib for alopecia areata
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Pharmacological Treatment of Alopecia